SETD2 heterozygous loss in leukemia leads to chemotherapy resistance through attenuation of the DNA damage response Meeting Abstract


Authors: Mar, B. G.; Kahn, J.; Zon, R. L.; Grauman, P. V.; Boettger, K.; Chu, S. H.; Armstrong, S. A.; Ebert, B. L.
Abstract Title: SETD2 heterozygous loss in leukemia leads to chemotherapy resistance through attenuation of the DNA damage response
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368020102138
PROVIDER: wos
DOI: 10.1182/blood.V126.23.2626.2626
Notes: Meeting Abstract: 2626 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Scott Allen Armstrong
    108 Armstrong
  2. Scott Haihua Chu
    7 Chu